VIRAX BIOLABS (UK) LIMITED

• 64209 - Activities of other holding companies n.e.c.

Virax Biolabs Group Limited is an innovative biotechnology company focused on the detection of immune responses to and diagnosis of viral diseases. In addition to distributing an array of in-vitro diagnostic test kits, Virax Biolabs Group Limited is currently developing T-cell based test technologies with the intention of providing an immunology profiling platform. T-cell testing can be particularly effective in the diagnosis and therapeutics of Long COVID as well as chronic inflammation and other post viral syndromes including myalgic encephalomyelitis, Hepaitis B, Malaria, Herpes and Human Papillomavirus... Virax Biolabs focuses on the propriety development and global distribution of diagnostic test kits with a particular emphasis on immunology.

Also known as: Virax Biolabs, Virax Biolabs Group, Virax Biolabs Group Limited

Registration numbers: 13630639 (CH)

Primary location: Newhouse United Kingdom